• Explore /
  • Poster
  • / Different organ-specific response to nivolumab to determine the survival outcome of patients with advanced hepatocellular carcinoma (aHCC).

Different organ-specific response to nivolumab to determine the survival outcome of patients with advanced hepatocellular carcinoma (aHCC).

Abstract Poster

Authors

Han Sang Kim

Han Sang Kim

Yonsei Cancer Center, Seoul, South Korea

Han Sang Kim , Jung Yong Hong , Jaekyung Cheon , Ilhwan Kim , Chang Gon Kim , Beodeul Kang , Dae Jung Kim , Chan Kim , Hongjae Chon , Hye Jin Choi , Ho Yeong Lim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4584)

DOI

10.1200/JCO.2020.38.15_suppl.4584

Abstract #

4584

Poster Bd #

192

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma.

Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma.

First Author: Alina Pascale

First Author: Mario Machado Lopes

First Author: Jarushka Naidoo

First Author: Lorenzo Pilla